TP53 and myeloid leukemia: Furthermore, SIRT1 knockdown resulted in cell cycle arrest, induction of apoptosis, and reduction of cell proliferation in K562 cells accompanied by enhanced p53 and FOXO1 acetylation in myeloid leukemia cells after etoposide treatment.